Having assessed the situation on its core markets, the fit of the company's near-term development portfolio and the existing operating portfolio ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 pm PT in San ...

GMT/BST   Britvic plc 7 January 2025   DIRECTOR/PDMR ...

Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth ...

Published extended data from the phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting MS in the peer reviewed journal, Neurology® Neuroimmunology & Neuroinflammation, an official ...

ZenaTech signed the LOI shortly before the end of the year. The Company anticipates closing on the acquisition before the end of January 2025. "This acquisition is part of a larger strategy to expand ...

Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: ...

STMicroelectronics Announces Status ofCommon Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Jan 2, 2025 to Jan ...

The Company announces that on 6 January 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1314 pence per share. Further details are set out below: ...

Cuxhaven, January 7, 2025 – At the beginning of the year, Dirk Simons took over as Chairman of the Supervisory Board of PNE AG from Marc van't Noordende, who had been Chairman of the Board on an ...

Gold prices moved to the downside during trading on Monday, extending the pullback seen during last Friday's session. Gold for ...